Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :16046551
Publication Date : //

Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.


Nuclear factor-kappaB (NF-kappaB) plays an important role during liver neoplastic development through transcriptional regulation of prosurvival genes, which then counteract the death-inducing signals elicited by the host immune response. The c-Myc proto-oncogene is frequently deregulated in liver tumors. Furthermore, enforced expression of c-Myc in the liver promotes the development of hepatocellular carcinomas, a process that is accelerated by coexpression with transforming growth factor-alpha (TGF-alpha). TGF-alpha/c-Myc-derived hepatocellular carcinomas display reduced apoptotic levels compared with those of single c-Myc transgenic hepatocellular carcinomas, suggesting that TGF-alpha provides a survival advantage to c-Myc-transformed hepatocytes. Given that TGF-alpha/c-Myc hepatocellular carcinomas display constitutive NF-kappaB activity, here, we have tested the hypothesis that enforced expression of TGF-alpha results in constitutive NF-kappaB activation and enhanced cell survival using TGF-alpha/c-Myc-derived hepatocellular carcinoma cell lines. We show that TGF-alpha induces NF-kappaB through the phosphatidylinositol 3-kinase/Akt axis in these bitransgenic hepatocellular carcinomas. Furthermore, we found that adenovirus-mediated inhibition of NF-kappaB activity impairs the ability of TGF-alpha/c-Myc-derived tumor cells to grow in an anchorage-independent fashion due to sensitization to c-Myc-induced apoptosis. Lastly, we show that NF-kappaB inhibits c-Myc-induced activation of caspase-9 and caspase-3 through up-regulation of the antiapoptotic target genes Bcl-X(L) and X-linked inhibitor of apoptosis (XIAP). Overall, these results underscore a crucial role of NF-kappaB in disabling apoptotic pathways initiated by oncogenic transformation.

Authors : Cavin Lakita G , Wang Fang , Factor Valentina M , Kaur Swayamjot , Venkatraman Manickam , Thorgeirsson Snorri S , Arsura Marcello ,

Related products :

Catalog number Product name Quantity
NFKBR-3 Refills, NF-kappaB, Nuclear Factor-Kappa Beta Activation Assay (NFKBR-3)
28-787 The nerve growth factor-induced clone C (NGFI-C_EGR4) gene is a zinc-finger transcription factor that is rapidly induced by nerve growth factor in rat pheochromocytoma PC12 cells and by seizure in bra 0.05 mg
10-288-23152 Transforming Growth Factor beta 2 (Human). E coli - Glioblastoma-derived T-cell suppressor factor; BSC-1 cell growth inhibitor; Polyergin; Cetermin; TGFB2 protein; Transforming growth factor beta-2; T 0.005 mg
10-288-23152 Transforming Growth Factor beta 2 (Human). E coli - Glioblastoma-derived T-cell suppressor factor; BSC-1 cell growth inhibitor; Polyergin; Cetermin; TGFB2 protein; Transforming growth factor beta-2; T 0.05 mg
RP17267230050 Transforming Growth Factor Beta Induced 182 a.a. 50 µg
RP17256860001 Transforming Growth Factor Beta Induced 1 mg
RP17256830020 Transforming Growth Factor Beta Induced 20 µg
RP17256830005 Transforming Growth Factor Beta Induced 5 µg
RP17267230010 Transforming Growth Factor Beta Induced 182 a.a. 10 µg
RP17267260001 Transforming Growth Factor Beta Induced 182 a.a. 1 mg
orb61378 Vargatef Vargatef is an indolinone derivative that potently inhibits vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR) and fibroblast growth factor r 25 mg
orb82693 Human Epiregulin protein Epiregulin is a member of the EGF family of growth factors which includes, amongothers, epidermal growth factor (EGF), transforming growth factor (TGF)-alpha, amphiregulin (AR 1 mg
E02T0171 Rat Transforming Growth Factor Beta Induced ELISA 96T/kit
TGF022 Transforming growth factor-beta-induced protein ig-h3 500
RPR-672 Recombinant Human Transforming Growth Factor Beta Induced 182 a.a. 10
RPR-568 Recombinant Human Transforming Growth Factor Beta Induced 5
pro-672 Recombinant Human Transforming Growth Factor Beta Induced 182 a.a. 1mg
pro-568 Recombinant Human Transforming Growth Factor Beta Induced 1mg
PRO-568 Recombinant Human Transforming Growth Factor Beta Induced 5µg
pro-568 Recombinant Human Transforming Growth Factor Beta Induced 5
PRO-568 Recombinant Human Transforming Growth Factor Beta Induced 20µg
PRO-568 Recombinant Human Transforming Growth Factor Beta Induced 1mg
PRO-672 Recombinant Human Transforming Growth Factor Beta Induced 182 a.a. 1mg
E13034h Human Transforming Growth Factor Beta 1 Induced Tr 96T
PRO-672 Recombinant Human Transforming Growth Factor Beta Induced 182 a.a. 10µg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur